ARTICLE | Company News
Inhale, Sheffield migraine deal
April 29, 2002 7:00 AM UTC
The companies partnered to develop an inhaled formulation of dihydroergotamine (DHE) to treat migraines. SHM will use its drug delivery technologies in combination with supercritical fluid technology ...